Episode 67
Biotech Hangout
00:00
Riada: A Unique Asset in the Neurology Sector
Before this morning was riada on your shortlist for biogen specifically? I don't think it's a surprise at all. It fits perfectly in you know, chris has talked about about liking orphan diseases as an orphan disease he's talked about having things adjacent or directly applicable to the neurology salas force This is this is that um and they've talked about kind of the near term, right? They needed a revenue line that's going to deliver relative immediately and and this is this are that and it's going to delivering growth too.
Transcript
Play full episode
